[Pegylated interferon treatment and severe thrombocytopenia].
Rodríguez-García
Guillermo
G
Jiménez-Macías
Fernando
F
Fernández-Jurado
Antonio
A
Domínguez-Macías
Agustín
A
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a